Source:http://linkedlifedata.com/resource/pubmed/id/18452070
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-5-8
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Boronic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide,
http://linkedlifedata.com/resource/pubmed/chemical/bortezomib,
http://linkedlifedata.com/resource/pubmed/chemical/lenalidomide
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1029-2403
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
833-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Current therapy of myeloma induced renal failure.
|
pubmed:affiliation |
Hematology, Mayo clinic, Rochester, USA.
|
pubmed:publicationType |
Journal Article,
Comment,
Review
|